PUBLICATIONS

Clinical Research Focus. 6th Edition Novartis Reports Final Positive Results of Zolgensma® Trial for Spinal Muscular Atrophy Spinal muscular atrophy (SMA) is a serious disease, which can lead to irreversible loss of motor function and death. In the SPR1NT study, Novartis’ gene therapy Zolgensma® proved effective in preventing the onset of symptoms before reaching all age-appropriate stages in children with spinal muscular Read more

Clinical Research Focus. 5th Edition Retinal Cell Map for the Treatment of Blinding Diseases Scientists from the National Eye Institute (NEI) have identified 5 subpopulations of retinal pigment epithelium (RPE). Researchers used Artificial Intelligence to analyze images of RPE, at single-cell resolution, to create a reference map that locates each subpopulation within the eye. “The findings will help us develop Read more

Сlinical trials in the Czech Republic – Country Profile 2022 CROMOS PHARMA IN THE CZECH REPUBLIC Cromos Pharma began working in the Czech Republic in 2010 and established a representative office in Prague in 2015. BACKGROUND The Czech Republic is a high-income country with a population of 10.69 million and a GDP of $245.33 billion (World Bank, 2020). Its largest city and capital is Prague Read more

Clinical Research Focus. 4th Edition Immune Response Against Viruses The new research from the Wyss Institute at Harvard University has revealed that every breath generates immune responses against invading viruses. This happens by stretching the tissues while inhaling and relaxing them while exhaling. Using a Human Lung Chip, that replicates the structures and functions of the lung air sac, the Read more